Recent Updates
Recently added Catalysts
CMPS Positive Sentiment

Compass Pathways to Debut U.S. HCP Education Campaign and Present New HEOR Data at Psych Congress 2026

Tuesday, September 8, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Compass Pathways plc is set to unveil its 'Change the Tune in TRD' educational campaign for U.S. healthcare professionals at Psych Congress 2026. The event, scheduled for September 14-19 in New Orleans, LA, will also feature new Health Economics and Outcomes Research (HEOR) data on treatment-resistant depression (TRD) and encore presentations of its COMP360 data.

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of a new educational campaign for healthcare professionals.
  • Presentation of new HEOR data at a prominent congress.
  • Focus on treatment-resistant depression (TRD), addressing a critical need.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~32 mo
Minimal dilution risk
Lead asset
Psilocybin
Phase 3 · Major Depressive Disorder

Full Press Release Details

LONDON & NEW YORK--(BUSINESS WIRE)---- $CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced its participation at Psych Congress 2026, taking place in New Orleans, LA, from September 14-19. The Company will debut Change the Tune in TRD, a new educational campaign for U.S. HCPs focused on TRD, and present new HEOR data examining the burden of TRD alongside encore presentations from its COMP360

Frequently Asked Questions

What is the focus of Compass Pathways' new campaign?

The campaign focuses on treatment-resistant depression (TRD) for U.S. healthcare professionals.

When and where will Psych Congress 2026 take place?

Psych Congress 2026 will be held in New Orleans, LA, from September 14-19.

What type of data will Compass Pathways present?

Compass Pathways will present new Health Economics and Outcomes Research (HEOR) data.

What is COMP360 in relation to Compass Pathways?

COMP360 refers to Compass Pathways' treatment data that will be presented at the congress.

ShareAdd on Google
Tags: CMPS Viatris Investor Conferences Healthcare Compass Pathways treatment-resistant depression HEOR data Psych Congress 2026
Last updated: Sep 8, 2026

Biotech snapshot

Cash runway
$433M liquidity · $13M/mo burn
~32 mo
Minimal dilution risk
Lead asset
PsilocybinPhase 3
Major Depressive Disorder →